chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced the inability to concentrate/think (felt like the days just went on and on without a distinctive beginning or ending). I also begin to see the appearance of red spots that wrapped around from my spine to approximately 1" above the belly button and continued to my right side. I went to my doctor 07/21/2021 and diagnosed me with Shingles which have been extremely painful since then.
I experienced shortness of breathe and constant chest pain, fatigue, throat soreness, and difficulty with the consumption of any food. I went to the ER for chest pain and test were run with no results. My doctor said she doesn't know what's wrong (multiple tests with no diagnosis).
Dizzy and lightheaded. Shortness of breath. Heart beating irregularly.   Outcome is nonischemic cardiomyopathy. Treating with lisinopril 20mg and metoprolol succinate 25mg
Information has been received from a 62 year old female patient referring to herself with blood pressure abnormal. The patient was allergic to anything with dye, metals or aluminum. Medical history was not reported. In approximately 2008 (reported as "about 7 years ago"), the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot# were not reported). In approximately 2011 (reported as "about 4 years ago") the patient experienced heart failure. In the beginning of June 2015, the patient was diagnosed with shingles. Concomitant medication included unspecified blood pressure medicine. The patient also mentioned that she went to an unspecified urgent care to seek medical attention on an unspecified date but was not admitted. On an unknown date the patient started therapy with famciclovir 500mg during 7 days as treatment of shingles. No lab diagnostic studies were reported. At the time of the report, the outcome of shingles was reported as resolved on approximately 07-JUL-2015 (reported as "about a week ago"). Outcome of heart failure was unknown. Additional information has been requested.
RIGHT LEG ALL SWOLLEN - NO PAIN - ONLY SWELLING. RIGHT LEG MEASURED 10 1/2 INCHES ABOVE KNEE, UPPER THIGH RIGHT 12 1/4. COMPARING TO LEFT 9 1/2 ABOVE KNEE AND UPPER THIGH 11 1/4.
Body aches, Fever (101), Chills -- patient has recovered from these Headache -- patient continues to have this symptom
10/16/02 Client phoned to state left arm was sore and very swollen. Requested client to come in for an assessment. 5:00 PM on 10/15/02 noticed soreness and swelling to left arm at injection site. Today 10/16/02 at 11:00 AM, there is redness noted from deltoid to elbow region--area is edematous and tender to touch. Looks like cellulitis. Temperature is 95.8 degrees F. Client was referred to MD for evaluation. Client saw MD today and was given a steroid shot for inflammation and placed on Keflex 500mg for 1 one.
Fevers, injection site redness, swelling, pain.  Appearance like cellulitis.
Intense itching and rash on soles of feet and palms of hand,. Bands of hives on trunk of body.   Intense lethargy.  Stomach pain.
Rash and itching at site one week after injections.  Would report via daily CDC Check but that didn?t come today for some reason
Dry mouth; Rash on back and lower front stomach area. Small oblong slightly raised, itchy.; Rash on back and lower front stomach area. Small oblong slightly raised, itchy.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 30Mar2021 at 12:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 21Apr2021 at 12:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included citalopram hydrobromide (CELEXA) and thyroid (ARMOUR THYROID); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced rash on back and lower front stomach area, small oblong slightly raised, itchy and dry mouth. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 21Apr2021, the patient underwent mouth swab and the result was negative. The clinical outcome of the events rash on back and lower front stomach area, small oblong slightly raised, itchy and dry mouth was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pulmonary embolism; Multiple clots in his lungs; Shortness of breath; This is a spontaneous report from a contactable consumer (patient wife). A 72-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown and expiration date not reported), via an unspecified route of administration on 10Feb2021 at a single dose for Covid-19 immunization.  The patient medical history was not reported. Concomitant medication included levothyroxine. The patient previously took first dose of bnt162b2 (EL8982) on 19Jan2021. The reporter (wife) stated that she and her husband both took the Covid vaccine. The patient (husband) is the one who have the adverse reactions. On 19Jan2021, she and her husband had the first shot, the Pfizer Covid shot. On 10Feb2021, they had the second shot. Just today she picked her husband from the hospital, they dismissed him for today because on 18Feb2021, she had to take him to emergency room because he had pulmonary embolism. He has multiple clots in his lungs. This is nothing that they dealt before with him. The reporter is afraid that it might be related to have taken the vaccine. Reporter stated that when she took him to the emergency room, it was 18Feb2021. Now he had a little shortness of breath for few days before the 18th but they didn't realize that he was having a big problem. He fully developed this on 18Feb2021. The reason for hospitalization was pulmonary embolism and blood clots in his lungs. He is little bit slow like the reporter said she got him to the hospital where he stayed 3 days she guess with pulmonary embolism, from 18Feb2021 to 21Feb2021. He had lot a of lab work while he was in hospital on these days the wife described. He had blood work, Echocardiogram, CAT scan, Ultrasounds, Chest X-ray, Covid rapid test, they haven't got back the result yet. Outcome of the events was unknown.
Information has been received from a physician concerning 2-4 children who were vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On an unspecified date the patients developed break through varicella. The physician has seen all 2-4 patients at his practice. On an unspecified date the patient's recovered. A product quality complaint was not involved. This is one of several reports received from the same source. Attempts made to obtain additional identifying information to distinguish the individual patients mentioned in this report were unsuccessful. Additional information has been requested.
This is to report that the second dose of Pfizer was administered 13 days after the first dose (i.e. more than 5 days before the due date), in error.
Terrible headache, insomnia, chills, aches, pains all over body, flu-like symptoms, went on for five days.
Dime sized pink spot on skin where vaccine was injected; soft, similar to blood blister. Not itchy or painful. Spot appeared ~1 week after being given, and still there today 6/24/21.
Vaccine-Related Anxiety (include misc. mental health); During her 15-minute waiting period after the injection, the patient began to experience light headedness; This is a spontaneous report from a non-contactable health care professional. A 66-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: Not reported), via an unspecified route of administration on an unspecified date as a 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient's medical history included wheel chair user. The concomitant medications were not reported. On an unspecified date, the patient experienced vaccine-related anxiety (include misc. mental health) and during her 15-minute waiting period after the injection, the patient began to experience light headedness, also reported that She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. Therapeutic measures were taken as a result of adverse events was as described in physical exam and with water. The outcome of all the events were recovered on an unspecified date.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
I have had intense joint/muscle pain in my knees, hips, shoulders and neck since getting the second vaccine. Initially the pain when I moved was 8 out of 10. I was okay sitting still but moving was very painful. It was been 19 days, and the pain is about 5 out of ten. I normally have no joint pain, except arthritis my hands and ankles. I had no headache or fatigue or any other side effects. I want to report this as an immunity-compromised person who ended up having very painful effects, which are lesser now but still unusual for me and painful. I did not report to doctor.
Myalgia, Fever, CoughWheeze, NauseaVomiting,  Sore throat, arm pain Narrative:  MD visit 1/4/21. CBC and Covid antibodies obtained. Started on azithromycin. Fever resolved w/in in 12 hours.
Patients were vaccinated with improperly stored vaccines; no adverse symptom; This non-valid spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On an unknown date, the patients were vaccinated with improperly stored doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # R012416, expiration date 28-OCT-2019) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot# N031003, expiration date 03-NOV-2019) (strengths, doses, frequencies and anatomical sites were unknown) all for prophylaxis, which had a temperature excursion on the range of 15°F to 46°F (21.6°F) for 12.5 hours. The temperature excursion was detected by a data logger and no adverse symptoms were reported.
Chills, Fever, Diarrhea, Headache, Exhaustion, Joint Aches  For 12-14 hours
After the injections the child developed sore lips then face redness and swelling which spread throughout torso with difficulty breathing.
Severe generalized fatigue and weakness. Headache and sence of sinus congestion.  Used ibuprofen.  Mostly resolved in 24 to 36 hours.
Individual had L side facial swelling and pain located along cheek bone and pain radiated into left ear.  Swelling was pronounced-received MMR approximately 16 days prior.
Information has been received from a consumer concerning her a 6 year old son with allergic to penicillin and 'sephacillin's" and no medical history who on 20-JUL-2009 was vaccinated with single dose of MMR II. There was no concomitant medication. On 25-Jul-2009 the patient developed a rash on his legs, arms and a slight rash on his trunk, had swollen lymph nodes that last about 24 to 48 hours and had a 103 degree fever for about three days. The patient saw his physician who did a blood test and a flu test and was told that the rash was a measles rash. The patient has been to the physician's office about four times now and was running a 100 degree to 102 degree fever on and off now for about two weeks. The patient had not recovered. Follow-up information has been received from the consumer who reported that tests had confirmed that her son did not have immunity to mumps. She also stated that he did have immunity to Rubella and that they are waiting on the test results regarding Measles. No further information is available.
PATIENT WAS GIVEN FLUAD, BUT IS ONLY 61 SO SHE IS BELOW THE APPROVED AGE. HAVE LEFT MESSAGE TO FOLLOW UP WITH PATIENT, STILL WAITING TO HEAR BACK.
still wasn't feeling too well; Slightly elevated temperature of 98.9; Breathing really fast; Headache; Shivering; This is a spontaneous report from a contactable nurse. A 73-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6203), via an unspecified route of administration on 21Feb2021 (about 9:20AM-9:30AM) at single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient was vaccinated with the first dose of BNT162B2 on an unspecified date at 73-year-old for COVID-19 immunization. The patient had his second COVID-19 Vaccine yesterday, 21Feb2021 and had a significant reaction. Last night (21Feb2021), about 12 hours later, he started getting a headache, he was breathing really fast, and shivering. He tried to calm himself down and went to bed. This morning (22Feb2021) he got up around 7AM and still wasn't feeling too well. His temperature was slightly elevated at 98.9 on 22Feb2021. His normal temperature is 97.1. He knows his own body and was pretty convinced his reaction was from a slightly elevated temperature and everything that comes with that. He went back to bed this morning and slept until 11:30AM. He got up and felt good. He took his temperature a few minutes ago and it was back to 97.1. The outcome of the events was recovered.; Sender's Comments: Based on temporal association and safety profile of the product, the contributory role of the suspect product  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6203), to reported events cannot totally be excluded.
Client received vaccine Hep A, Hep B & Td booster. Client passed out about 5 min after receiving vaccines. She started having a seizure, shaking, foaming @ the mouth & urinated on herself. O2 per face mask. Client transfered via ambulance to hospital.
she had an allergic reaction; This is a spontaneous report from a contactable consumer (patient, self-reported). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EK9231), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced she had an allergic reaction on an unspecified date. It was reported that Caller would like to know if there are clinical trials she could volunteer for. She took the Pfizer vaccine when it first came out, and she had an allergic reaction. She was only able to take one, and not two. She was wanting to know if Pfizer was doing clinical trials for the booster, and if they are also doing anything for people that have had an allergic reaction to the vaccine. The outcome of events was unknown.
Pain at injection for 4 days; Numbness/tingling at injection for 3 hours; Numbness/tingling at injection for 3 hours; Flushing for 4 days; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection and lot number: EJ1685) via an unspecified route of administration in left arm on 05Jan2021 10:35 (at the age of 30 years). as dose 1, single dose for COVID -19 immunization (Hospital, Workplace clinic). The patient medical history and concomitant medications were none. Vaccine Administered at Military Facility was no. The patient did not have a history of any previous allergies to specific products or any conditions indicative of an allergy. Patient was not taking any medication prior to the event being reported. The patient did not receive any recent vaccines for other conditions prior to the event being reported. The patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-Biontech COVID-19 vaccine prior to the event being reported. The patient did not receive any other vaccines around the time of Pfizer biotech COVID -19 vaccine vaccination. In Jan2021 the patient experienced pain at injection for 4 days, flushing 4 days. Numbness/ tingling at injection for 3 hours. It was reported that there was no multiorgan involvement, respiratory, difficulty breathing, sensation of throat closure, sneezing, rhinorrhea, cardiovascular, measured hypotension, shock, tachycardia, capillary refill time>3sec, reduced central pulse volume, decreased level of consciousness, loss of consciousness, dermatological/mucosal, generalised urticaria, generalised erythema, angioedema, generalized pruritus with skin rash, generalized pruritus without skin rash, generalised prickle sensation, localised injection site urticaria, red and itchy eyes, gastrointestinal, diarrhea, abdominal pain, nausea, vomiting, any other sign/symptoms. Patient did not receive any new medication or treatment or procedure for the events. AE does not require a visit to Emergency room or physician room. The patient was bot admitted to hospital. The patient did not provide the information regarding the reported adverse events with the use of the product. The outcome of the events was unknown.  No follow-up attempts are possible. No further information was provided.
pain, numbness and tingling up and down my arm, neck pain, headaches, fever (twice since vaccine), excruciating joint pain, nausea, fatigue, rash at injection site--all this for 13 days non stop.
About 12 hours after receiving vaccine he reports sudden onset vertigo. Some nausea. Felt off-balance.
Second shot has even more severe symptoms than the first. This report is for the second dose. Symtoms started around 12 hours after injection. Puking continuously for 3 days. Could not get out of bed so weak and could not keep fluids down. Very bad vertigo / dizziness for one week & then off and on for the next three weeks. Would wake up in the middle of the night and be extremely dizzy & then puke. Fever between 100-103 for the first week after. Would spike high to 103 and sometimes not be contained with Tylenol. Fever continued off and on for a whole month after. I would take temperature multiple times a day to monitor.  Would normally spike high before bed at the highest. Extreme fatigue and  brain fog for a month.  No appetite for a month. Normally do not menstruate at all due to birth control, however, after  first vaccine became menstruating and it continued until the second shot & after the second shot the flow became even heavier. It did not stop until four months after the vaccine & now I am still spotting regularly and still very very heavy on certain days
Headache, Myalgia, Arthralgia, Fever, ErythemaMultiform, fatigue; arm sore, red and swollen Severe headache, fever 101, arthralgia, myalgia, arm redness/swelling, fatigue; took ibuprofen; recovering but arthralgia and fatigue lingering.
This spontaneous report was received from a registered nurse refers to a "65 years old" patient. The patient was vaccinated with VARIVAX (Merck) (lot# 1216AA) instead of ZOSTAVAX. It was reported that the vaccine was indicated for the prevention of shingles. Additional information has been requested.
Patient received J&J x 1 on 9/29/21. Presented to ER on 6/6/22 and found to be covid positive. Was admitted. Workup included COVID-19 testing which was positive.  He was mildly hypoxic.  He has significant risk factors with COPD with continued nicotine addiction.  Was started on remdesivir and dexamethasone as well supplemental oxygen per protocol, appropriate quarantine, and  azithromycin and ceftriaxone.  Was started on Breo Ellipta.  Initially was in the ICU.  Of note had 1 J and J vaccine but no booster.  Over the next 72 hours he improved and was titrated off oxygen by discharge.  Was counseled repeatedly regarding smoking cessation.  In regards to syncope had echocardiogram which was unremarkable and was on telemetry without issues.  Had no further episodes.  Blood pressure medications were held tried his hospital stay but by the time of discharge blood pressure was starting to elevate.  By the above date he was tolerating his usual activity and discharged home. Discharged on 6/10/22
JANSSEN COVID-19 VACCINE ADMINISTERED POSSIBLE TEMPERATURE EXCURSION; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-APR-2021, the subject experienced janssen covid-19 vaccine administered possible temperature excursion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of janssen covid-19 vaccine administered possible temperature excursion was not reported. This report was non-serious.
fed @ 3AM 21OCT then 7AM mom heard a squeky sound-saw pt w/legs/arms threshing-eyes rolled back-intermittently crying lasted 3-5mins then sleepy briefly the fine; adm to hosp;septic w/u done neg
Pain, numbness in hand (Lt) started 5 min after injection. Throat tightness started in about 25 min (mild). Resolved after epinephrine injection. BP min 80/50/before EPI injection.
swelling in the shot area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling in the shot area) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling in the shot area). At the time of the report, VACCINATION SITE SWELLING (swelling in the shot area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications are provided. No treatment medications are provided
About a month after receiving the third and final dosage of the GARDASIL medication, I began having absent seizures. I have now been diagnosed with epilepsy. My neurologist says that it is, more than likely, going to stay with me for the rest of my life.
During vaccination felt flushed and dizziness.  Went home and arm was sore as expected.  As night progressed, around 6-8pm, arm got achy and sore.  Took an Epsom salt bath. Went to bed got headache, shivering, and achy.  Did not take any medicine that day.  Today, patient feels nauseous--took nauseous meds--, feverish, achy, and shivering. Patient has bad headache--but has not taken migraine meds--, feels disoriented, and clumsy.   Patient has disability and if she had known the adverse events would be as severe she would have planned better to get help.  She just feels sick, and there is a 3-inch area of redness and swelling at vaccination site. She does not feel like she could even drive right now.   Patient planning to take the 2nd dose since needs to be covered and avoid future shingles outbreaks.
Patient was administered Zostavax instead of Varivax.  *This would have been the patient's second dose of Varicella vaccine*.  Her first dose was on 7-14-03.